How Can We Further Address Residual Risk?

A 65-year-old female presents with Type 2 Diabetes for 10 years, without known cardiovascular disease, has hypertension, an HbA1c of 8%, an LDL-C of 80 mg/dL on atorvastatin 80 mg, triglycerides of 175 mg/dL, and is a non-smoker.

What evidence-based therapy would you recommend to further reduce her cardiovascular disease risk?

Show Answer